Alexion to Pick Goldman to Advise on Roche Offer?
July 30 (Bloomberg) -- Alexion Pharmaceuticals, the drugmaker whose blood-disease treatment is among the world’s most expensive medicines, engaged Goldman Sachs as an adviser as it prepares for a possible takeover offer from Roche, said people with knowledge of the matter. Cristina Alesci reports on Bloomberg Television's "Money Moves." (Source: Bloomberg)
Most Recent Videos
Creating a One-Stop Shop for A.I. Integration
04:14 - Businesses of all stripes are doing their best to integrate big data, artificial intelligence and machine learning into their workflows. Optix Solutions is trying to take the stress out of the transition. Globalive Chairman Anthony Lacavera asks Spencer Fung, founder and CEO of Optix Solutions, about the objective behind the company. (Source: Bloomberg)